Treatment of posttraumatic stress disorder with nefazodone

International Clinical Psychopharmacology

Volumn 13, Issue 3, 1998, Pages 111-113

  Davidson, J R T ^a   Weisler, R H ^a,b   Malik, M L ^a   Connor, K M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Duke University Medical Center ^*

Author keywords

5 HT2 antagonist; Nefazodone; Posttraumatic stress disorder

Indexed keywords

NEFAZODONE; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; MALE; NIGHTMARE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SLEEP DISORDER;

EID: 0031820944     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199805000-00003     Document Type: Article

References (19)

1. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association.
2. Davidson JRT, Colket J (1997). The TOP-8: a brief measure to assess treatment outcome in PTSD. Internat Clin Psychopharmacology 12:41-45.
3. Davidson JRT, Kudler HS, Smith R (1989). Validity and reliability of the DSM-III criteria for posttraumatic stress disorder. J Nerv Ment Dis 177:336-341.
4. Davidson JRT, Kudler H, Smith R, Mahorney SL, Lipper S, Hammett EB, et al. (1990). Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry 47:259-266.
5. Davidson JRT, Book SW, Colket JT, Tupler LA, Roth S, David D, Hertzberg M, et al. (1997). Assessment of a new self-rating scale for post-traumatic stress disorder. Psych Med 27:143-160.
6. Davidson JRT, Malik MA, Travers J (1997). Structured Interview for PTSD (SIP): Psychometric Validation for DSM-IV Criteria. Depression and Anxiety 5:127-129.
7. Deakin JFW (1983). Roles of serotonergic systems in escape, avoidance, and other behaviors. In: Cooper SJ, editor. Theory of psychopharmacology. London: Academic Press, pp. 149-193.
8. De Boer M, Op den Velde W, Falger PJR, Hovens JE, De Groen JH, Van Duijn H (1991). Fluvoxamine treatment for chronic PTSD: a pilot study. Psychother Psychosom 57:158-163.
9. Hamilton M (1959). The assessment of anxiety states by rating. Br J Med Psychol 32:50-55.
10. Hensman R, Guimares FS, Wang M, Deakin JF (1991). Effects of ritanserin on aversive classical conditioning in humans. Psychopharmacology 104:220-224.
11. Hertzberg MA, Feldman ME, Beckham JC, Davidson JRT (1996). Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design. J Clin Psychopharmacology 16:294-298.
12. Horowitz M, Wilner N, Alvarez W (1979). Impact of Event Scale: a measure of subjective distress. Psychosom Med 41:209-218.
13. Joseph MM, Kennett GA (1983). Corticosteroid response to stress depends upon increased tryptophan availability. Psychopharmacology 79:79-81.
14. Katz RJ, Lott MH, Arbus P, Crocq L, Herlobsen P, Lingjaerde O, et al. (1995). Pharmacotherapy of posttraumatic stress disorder with a novel psychotropic. Anxiety 1:169-174.
15. Kline NA (1994). Sertraline efficacy in depressed combat veterans with posttraumatic stress disorder. Am J Psychiatry 151:1-62.
16. Kosten TR, Frank JB, Dan E, McDougle CJ, Giller EL Jr (1991). Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis 179:366-370.
17. Marmar CR, Schoefeld F, Weiss DS, Metzler T, Zatzick D, Wu R, et al. (1996). Open trial of fluvoxamine treatment for combat-related posttraumatic stress disorder. J Clin Psychiatry 57(Suppl 8):66-72.
18. Sheehan DV, Lecrubier Y, Janaus J, Knapp E, Weiller E, Bonora LI, et al. (1994). Mini International Neuropsychiatric Interview (MINI). Tampa, FL: University of South Institute for Research in Psychiatry and Paris: INSERM - Hôpital de la Salpétrière.
19. van der Kolk BA, Dreyfuss D, Michaels M, Shera D, Berkowitz R, Fisher R, Saxe G (1994). Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry 44:517-522.